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Summary
We describe two signaling events downstream of ERK-MAP kinase contributing to cell motility in colon carcinoma cells.
The Fos family member Fra-1 is expressed in an ERK-dependent manner. Silencing of Fra-1 expression with short interfering
RNAs leads to losses of cell polarization, motility, and invasiveness in vitro. These effects of ablating Fra-1 are a consequence
of activation of a RhoA-ROCK pathway by 1-integrin, leading to an increase in the amount of stress fibers and stabilization
of focal adhesions. We propose that Fra-1 promotes cell motility by inactivating 1-integrin and keeping RhoA activity
low. This depression of RhoA activity is necessary to permit a second ERK-dependent signaling event via uPAR, the
receptor for urokinase-type plasminogen activator, to activate Rac and to drive motility through polarized lamellipodia
extension.
Introduction (Amano et al., 1997; Watanabe et al., 1999). The role of Rho in
cell movement is less clear; its activity is required to induce
Unraveling the signaling pathways responsible for the establish- actomyosin contractility, driving the translocation of the cell
ment of a metastatic phenotype in carcinoma cells is of crucial body retraction at the rear (Allen et al., 1997). Nevertheless, Rho
importance for the understanding of the pathology of cancer. may also negatively influence cell migration by increasing stress
The process of metastasis has several components including fiber-dependent adhesions to the substrate (Cox et al., 2001).
the ability to invade through acquisition of cell motility, degrada- A tight control of the activity of Rho seems to be required
tion of extracellular matrix and basement membranes, survival to balance the opposing effects of cell body contraction and
signaling, and cell proliferation. At present, it is not clear whether adhesion.
there are distinct metastatic genes activated during tumor pro- As well as contributions of the Rho family GTPases to the
gression or whether oncogenes and tumor suppressor genes, metastatic phenotype, several lines of evidence point to involve-
activated at earlier stages of oncogenesis, are the major genetic ment of Ras oncoproteins (Varghese et al., 2002; Webb et al.,
changes contributing to the metastatic phenotype (Bernards 1998). Three classes of Ras effectors are now well established:
and Weinberg, 2002). the Raf family of protein kinases, phosphatidylinositol-3 kinases
Much evidence points to the involvement of the Rho family
(PI3Ks), and the Ral guanine nucleotide exchange factors (Ral-
of GTPases in cell motility and invasive phenotypes (Jaffe and
GEFs) (Downward, 1998; Marshall, 1996; Wolthuis and Bos,Hall, 2002). Rho family members Rac, Cdc42, and RhoA are key
1999). The Raf kinases phosphorylate the dual specific kinaseregulators of the actin cytoskeleton (Hall, 1998). In the process of
Mek, which in turn phosphorylates and activates the MAP ki-cell migration, Rac is required for the formation of lamellipodia
nases ERK1 and ERK2. The role of Raf-ERK MAP kinase signal-at the leading edge of the migrating cells and is thought to be
ing downstream of Ras has been highlighted in a number ofthe driving force for cell movement (Jaffe and Hall, 2002). Cdc42,
studies of invasive growth (Janda et al., 2002; Webb et al.,while not directly required for cell movement, has been sug-
1998). The importance of signaling through Raf in oncogenesisgested to be involved in the regulation of cell polarity, controlling
is emphasized by the discovery of oncogenic mutations of BRAFthe direction of cell movement (Allen et al., 1998; Nobes and
(Davies et al., 2002). The ERK-MAPK signaling pathway acti-Hall, 1999). Rho regulates the assembly of actin stress fibers
vated by Raf appears to be of critical importance since its inhibi-and associated focal adhesions through activation of its down-
stream effectors mDia and the ROCKI and ROCKII kinases tion abolishes growth in mice of the HT29 human colon tumor
S I G N I F I C A N C E
The acquisition of cell motility is a key property of tumor cells with an invasive phenotype. We show that the ERK-MAPK pathway
downstream of oncogenic Ras can regulate the activity of the small GTPases Rac and RhoA and thereby contribute to tumor cell
motility and invasion. ERK-MAPK signaling to RhoA is via transcriptional upregulation of the Fra-1 transcription factor and to Rac via
transcriptional upregulation of the urokinase receptor (uPAR). Those two molecules are responsible for the coordinated regulation
of GTPase activity permitting the formation of cellular protrusions. Thus, inhibition of ERK-MAPKs may provide a route to blocking
tumor cell motility and invasion as well as proliferation.
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cell line that contains an activating BRAF mutation (Sebolt- protein expression was dramatically reduced (90%–95%), as
soon as 2 days after transfection, and the silencing persistedLeopold et al., 1999).
Activated ERKs have many substrates including cytosolic, for more than 6 days (ten generations) (Figure 1A). After transfec-
tion of the siRNAs, most of the immunofluorescence staining forcytoskeletal components, and transcription factors. The AP-1
family of transcription factors are known to be targets of ERK nuclear Fra-1 disappeared, confirming its functional inhibition
(Figure 1B). Furthermore, the overall AP-1 DNA binding activitysignaling. AP-1 consists of dimers composed of transcription
factors of the Jun (c-Jun, JunB, and JunD) and Fos (c-Fos, in BE cells, essentially composed of c-Jun and Fra-1, was re-
duced by 90% upon Fra-1 silencing (Supplemental Figure S1FosB, Fra-1, and Fra-2) families (Angel and Karin, 1991). AP-1
has been shown to be a major mediator of transformation by online at http://www.cancercell.org/cgi/content/full/4/1/67/DC1).
BE cells display strong invasive properties in vitro. TheseRas (Mechta et al., 1997). The signaling pathway from Ras to
AP-1 appears to be through the Raf-ERK MAP kinase cascade tumor cells efficiently migrate through a three-dimensional Ma-
trigel matrix, but upon inhibition of Fra-1 expression, the propor-since signaling through Raf and Mek1 (Treinies et al., 1999)
modifies AP-1 activity and composition. The importance of AP-1 tion of invading cells was reduced by more than 80% (Figure
1D). Most of the cells remained at the bottom of the filter (andactivity for Ras-dependent transformation has been demon-
strated in a number of studies in which c-Jun inhibition has in the filter), where initially seeded, and were unable to enter
and migrate through the Matrigel (Figure 1C). This decreasebeen shown to revert the transformed phenotype induced by
Ras in fibroblasts (Johnson et al., 1996; Lloyd et al., 1991; Suzuki was not due to a defect in cell growth since Fra-1 silencing
did not affect cell proliferation (data not shown); instead, weet al., 1994). In contrast to c-Jun, a requirement for c-Fos in
Ras-mediated transformation is less clear. Fra-1 is the predomi- observed that random motility on a tissue culture dish was
severely impaired. The average migration speed was reducednant Fos family protein contributing to AP-1 activity in Ras- and
Mek1-transformed fibroblasts (Mechta et al., 1997; Treinies et from approximately 18 to 1.8 m/hour (Figure 1E). This loss of
motility is likely to be responsible, at least in part, for the lossal., 1999). The ERK-MAPK pathway controls Fra-1 expression
transcriptionally and posttranscriptionally in colon carcinoma of invasiveness. These observations show that in BE colon carci-
noma cells, Fra-1 (AP-1) activity is required for motility andcells containing KRAS oncogenes (E.V. and C.J.M., unpublished
results). An important role for Fra-1 in Ras-induced tumorigene- invasiveness. A similar effect on cell motility was observed when
Hct-116, a colon carcinoma cell line, which contains a KrasG13Dsis is suggested by the fact that antisense-mediated inhibition
of Fra-1 antagonizes the Ras-induced colony formation in soft oncogene, was transfected with Fra-1-specific siRNAs (see
Supplemental Movies S1A and S1B on Cancer Cell website).agar of thyroid cell lines (Vallone et al., 1997).
We demonstrate that ERK-MAPK-dependent expression of
Fra-1 is required for motility and invasiveness of colon carci- Fra-1 downregulates Rho-GTP but does not alter Rac
or Cdc42 levelsnoma cells. We show that Fra-1 suppresses 1-integrin signal-
ing, resulting in the downregulation of RhoA activity. Depression We next sought to determine the mechanism by which Fra-1
regulates motility. Small GTPases of the Rho family play keyof Rho-GTP levels prevents ROCK from inducing excessive
contractile and adhesive forces, which would lead to increased roles in regulating the actin cytoskeleton and the cellular re-
sponses required for cell migration (Ridley, 2001). A link betweenfocal adhesions, inhibition of protrusions, and loss of cell motil-
ity. We propose that Fra-1 promotes motility in cancer cells by AP-1 and Rho-GTPase function in invasion has been suggested
by a study showing that c-Jun activity is necessary, upstreamkeeping RhoA activity low. In addition, we show that the activa-
tion of Rac required for cell motility can also be mediated by of Rho-like GTPases, for EGF-induced cell motility and invasive-
ness (Malliri et al., 1998). RhoA, Rac, and Cdc42 activities wereERK-MAPK signaling. We provide evidence for a Fra-1-indepen-
dent role of ERK signaling, via expression of uPAR, to activate assessed in pulldown assays by measurement of the levels of
active, GTP bound proteins. Upon Fra-1 inhibition, the levels ofRac and regulate lamella/ruffling activity. Our data suggest that
in colon carcinoma cells, there are two signaling pathways active RhoA were increased with no change in RhoA expression
(Figure 2A), demonstrating that Fra-1 inhibits RhoA activity indownstream of ERK regulating motility and invasiveness: (1) a
Fra-1-dependent pathway leading to the downregulation of BE cells. In contrast, the levels of active Rac and Cdc42 were
not altered.RhoA necessary for the extension of the ruffles into active ex-
tending protrusions; (2) a Fra-1-independent uPAR-dependent We next analyzed the effect of Fra-1 inhibition on cell mor-
phology and actin organization. BE cells are strongly dedifferen-pathway leading to the activation of Rac1 and the initial forma-
tion of ruffles. tiated carcinoma cells. Phase contrast analysis showed that BE
cells display very elongated, mainly bipolar, fibroblastoid shape
(Figure 2B). They migrated as single cells, forming extendedResults
protrusions followed by translocation of the cell body (Supple-
mental Movie S2A on Cancer Cell website). Upon Fra-1 inhibi-Fra-1 RNAi decreases tumor cell motility and invasion
Fra-1 is the Fos family member predominantly expressed in tion, the cells became rounder and flatter and did not form
protrusions. This was accompanied by a dramatic increase inHct-116 and BE colon carcinoma cells and is regulated by the
ERK-MAPK pathway via both transcriptional and posttranscrip- the number of stress fibers and in the size and number of focal
adhesions (Figure 2B), consistent with an increase in RhoA-tional mechanisms (E.V. and C.J.M., unpublished results). To
investigate the role of Fra-1 in colon cancer cells, short interfer- GTP. In fibroblasts, the formation of protrusions, which are the
driving force of cell movement, is dependent upon the creationing RNAs (siRNAs) specific for the fosL1 gene, which encodes
Fra-1, were transfected into BE cells. BE cells contain an onco- of Rac-dependent (Ridley et al., 1992), actin-rich structures at
the leading edge of the cell, forming membrane ruffles. Consis-genic KrasG13D mutation as well as a BRAF oncogenic mutation
G463V (Davies et al., 2002). As shown by immunoblotting, Fra-1 tent with the absence of an effect on Rac-GTP, Fra-1-silenced
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Figure 1. Fra-1 silencing inhibits cell motility and invasiveness
A: Immunoblot analysis of Fra-1 expression in BE cells after transfection of fosL1-specific siRNAs to silence Fra-1 expression or scrambled siRNAs.
B: Immunofluorescence analysis of Fra-1 expression in BE cells 48 hr after transfection of fosL1 or scrambled siRNAs. Bars, 15 m.
C: Three-dimensional representations of fluorescence of GFP-expressing BE cells (BE-GFP) in Matrigel invasion assays. Forty-eight hours after transfection of
siRNAs, cells were seeded at the bottom of the filter and allowed to migrate into Matrigel toward the chemoattractant (top) for 4 days.
D: Quantitative analysis of invasion of silenced and control BE-GFP cells. Values represent mean  SD of two independent experiments.
E: Random migration of Fra-1-silenced or control BE cells was recorded by timelapse microscopy. A minimum of 20 cells was monitored in three independent
experiments. Values represent mean cell speeds  SD from one representative experiment.
BE cells still displayed ruffling activity, but unlike control cells from the absence of extending protrusions associated with an
increase in RhoA activity, stress fibers, and focal adhesionsruffles were all around the cell and not localized to a leading
edge. Furthermore, these ruffles did not extend into protrusions rather than loss of membrane ruffles.
The ERK-MAPK pathway controls Fra-1 expression in these(Supplemental Movie S2B on Cancer Cell website). These re-
sults show that upon Fra-1 silencing, loss of motility results colon carcinoma cells (E.V. and C.J.M., unpublished results).
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Figure 2. Fra-1 silencing increases Rho-GTP levels,
stress fibers, and focal adhesions
A: Forty hours after transfection of siRNAs, pull-
down assays were performed for GTP bound
RhoA, Cdc42, or Rac.
B: Control and Fra-1-silenced cells were visual-
ized by phase contrast microscopy or staining
with anti-vinculin antibody or Texas red-coupled
phalloidin for F-actin. Bars, 15 m.
C: Control BE cells and cells treated for 18 hr with
the Mek inhibitor UO126 were stained for F-actin.
We therefore tested whether inhibition of the ERK-MAPK path- Elevated Rho-GTP suppresses motility
The above experiments suggest that the increased RhoA activityway with the Mek inhibitor U0126 could recapitulate the effects
resulting from Fra-1 inhibition might be the cause of increasedinduced by Fra-1 inhibition. We found that upon Mek inhibition,
stress fiber formation and focal adhesions, which in turn inhibitas for Fra-1 inhibition, BE cell motility was dramatically reduced
protrusions and cell motility. To test this hypothesis, we microin-(Supplemental Movie S3 on Cancer Cell website), and there
jected BE cells with a constitutively active RhoA mutant (RhoA-was also an increase in stress fibers and focal adhesions (Figure
V14). The microinjected cells were much rounder than the con-2C and data not shown). These effects on cytoskeleton and cell
trol cells and were completely devoid of protrusions (Figures
motility only started after 10–12 hr of U0126 treatment, when
3A and 3D), and, like cells in which Fra-1 had been silenced,
Fra-1 protein levels were efficiently suppressed (80% reduc- RhoA-V14-expressing cells displayed membrane ruffles all
tion) (data not shown). In contrast to Fra-1 inhibition, Mek inhibi- around the periphery of the cell (data not shown). The motility
tion resulted in the inability to form ruffles, suggesting that in of the RhoA-V14-expressing cells was dramatically reduced
these cells, ruffling activity is dependent on the ERK-MAPK (Figure 3E), consistent with the hypothesis that high RhoA activ-
pathway, but is independent of Fra-1 (Supplemental Movie S3 ity suppresses motility by preventing Rac-induced protrusions.
Contrasting with the inhibition of Fra-1 expression, however,online).
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Figure 3. Rho activity antagonizes cell motility
A: BE cells were microinjected with EF-RhoA-V14 and EGFP-C1 and incubated for 6 hr before fixation and staining for F-actin. Microinjected cells were
identified using GFP fluorescence.
B: BE cells were transfected with fosL1 or scrambled siRNAs, incubated for 24 hr, then Y27632 (10 m) or Tat-C3 (0.5 m) was added and the cells were
incubated for a further 24 hr before staining for F-actin.
C: BE cells were transfected with fosL1 siRNAs, incubated 42 hr, microinjected with EF-DiaNC, and incubated for 6 hr before staining for F-actin.
Microinjected cells were identified by staining with anti-myc antibody.
The average length/width ratios (polarized phenotype) of the EF-RhoA-V14 microinjected cells (D), Y27632- and Tat-C3-treated cells (F), and EF-DiaNC
microinjected cells (H) and the corresponding control cells were calculated and the motility of the same cells recorded (E, G, I, respectively). A minimum
of 20 cells was monitored in each experiment. Results are representative of 2–3 independent experiments. Statistical significance was evaluated by
calculating p values: (C) compared to control cells, (S) compared to Fra-1-silenced cells. Bars, 15 m.
the RhoA-V14-expressing cells did not display large stress fibers Rho effector mDia (DiaNC) did not lead to the disruption of
but instead a very large actin-rich network at the cell border stress fibers and restoration of protrusions or motility (Figures
(Figure 3A). These results argue that elevated levels of RhoA- 3C, 3H,and 3I). These data demonstrate that RhoA and ROCK
GTP in BE cells inhibit the formation of protrusions, polarized but not mDia functions are required to inhibit protrusions and
phenotype, and motility, probably via the reorganization of the motility upon Fra-1 inhibition.
actin cytoskeleton. These results argue that upon Fra-1 inhibition, the increase
To confirm that Rho signaling led to the loss of protrusions in Rho-GTP levels is responsible, via ROCK and the reorganiza-
and motility, treatment with cell-permeable C3 toxin disrupted tion of the actin cytoskeleton, for the lack of protrusions and
stress fibers and focal adhesions and partially restored mem-
inhibition of motility.
brane protrusions and motility in Fra-1-silenced cells (Figures
3B, 3F, and 3G). Inhibition of the Rho effector ROCK/Rho-kinase
Fra-1 suppresses 1-integrin signaling to Rho-GTPusing the synthetic inhibitor Y27632 also restored polarized
We next sought to determine the relationship between Fra-1phenotype and motility in those cells (Figures 3B, 3F,and 3G).
In contrast, microinjection of a dominant-negative mutant of the and RhoA-GTP levels. The composition of the extracellular ma-
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trix and specific integrin signals can influence the adhesive and vated 1-integrins on adjacent cells (Figure 4F). These struc-
tures may increase intercellular adhesion and thereby contributemigratory response of cells via the regulation of the Rho family
of small GTPases. Integrin engagement has been shown to to decreased cell motility. We also observed that these struc-
tures were connected to stress fibers inside the cells.regulate Rho activity in a complex fashion. Initial adhesion of
suspended cells to fibronectin can transiently depress RhoA To determine whether 1-integrin signaling was involved in
the activation of RhoA, we silenced its expression using RNAiactivity (Arthur and Burridge, 2001), but more sustained interac-
tion leads to Rho activation whose magnitude is dependent (Figure 5A) or inhibited its function with blocking antibodies.
Silencing of 1-integrin abrogated the increase in Rho-GTPon fibronectin concentration (Cox et al., 2001). Integrins also
regulate Rac and Cdc42, leading to cell spreading and adhesion seen in Fra-1-silenced cells (Figure 5B, upper panel). A similar
inhibition of Rho activation was observed when we used 1-(del Pozo et al., 2000; Price et al., 1998).
To determine whether, upon Fra-1 inhibition, integrin signal- integrin-blocking antibody (AIIB2) in Fra-1-silenced cells (Figure
5B, lower panel). These results indicate that activation of 1-ing was responsible for RhoA activation, we analyzed ex-
pression of a wide range of integrin subunits. Using a series integrin signaling is required for the activation of Rho when
Fra-1 is silenced. To confirm these results, we investigatedof conformation-dependent monoclonal antibodies (9EG7,
HUTS-4, HUTS-21, 12G10, 15/7) which detect the activated whether activation of 1-integrin signaling in BE cells could lead
to the activation of RhoA. Incubation of BE cells with a 1-state of 1-containing integrins (Lenter et al., 1993; Luque et
al., 1996; Mould et al., 1995; Picker et al., 1993), we found that integrin-activating antibody (TS2/16) led to an increase in Rho-
GTP, to levels similar to those seen after inhibition of Fra-1staining for activated 1-integrin was seen upon Fra-1 silencing
(Figure 4A and data not shown). In contrast, both control and (Figure 5C). In Fra-1-silenced cells, TS2/16 did not produce a
further increase in Rho activity, indicating that physiologicalFra-1-silenced cells were stained using pan-1-integrin anti-
bodies such as P5D2 (Figure 4A) or K20 (data not shown). Similar maximum levels were reached. Altogether, these results demon-
strate that upon Fra-1 inhibition, activation of 1-integrin signal-results were found when Mek was inhibited in BE cells (data not
shown). Each of these antiactive 1 antibodies demonstrated a ing is responsible for the activation of RhoA. Consistent with
this conclusion, rather than Rho signaling activating 1-integrinfibrillar staining pattern on Fra-1-silenced cells, but did not stain
control BE cells (9EG7, HUTS-21, 15/7) or showed a low diffuse signaling, we found that microinjection of BE cells with con-
structs expressing RhoA-V14 or an active version of ROCK1staining (12G10, HUTS-4). While 12G10 has been shown to
detect activated integrin irrespective of ligand occupancy (ROCK1C) did not lead to the formation of active 1 complexes
although they induced formation of focal adhesions (Figure 5D).(Mould et al., 2002), it has been suggested that antibodies, such
as 9EG7, detect activation-specific epitopes only if ligand is
present (Bazzoni et al., 1995). Figures 4B and 4C show that An ERK-uPAR-Rac pathway is required
for ruffling activitysilencing Fra-1 leads to increased expression of fibronectin,
and therefore it is possible that the increased staining with As described earlier, Fra-1-silenced BE cells still formed ruffles.
In fibroblasts, the small GTPase Rac has been shown to be theactivation-specific antibodies is a consequence of increased
ligand production. To test this possibility, we added exogenous driving force of cell movement by regulating the formation of
membrane ruffles at the leading edge of cells (Ridley et al.,fibronectin to control BE cells and to Fra-1-silenced cells. Stain-
ing with activation-specific antibodies, 9EG7 (Figure 4D), and 1992). In BE cells, ruffling activity and motility are dependent
on Rac, as shown by microinjection of dominant negative Rac-HUTS-21 (data not shown) was seen in the silenced cells and
it was increased in the presence of fibronectin, but no active N17 (Figure 6A and Supplemental Figure S2 and Movie S4 on
Cancer Cell website).1-integrin was detected in the control cells with or without
exogenous fibronectin. Thus, the increased detection of active While silencing Fra-1 did not block membrane ruffling, inhibi-
tion of ERK1/2 MAPK activation by treatment with the Mek1 in Fra-1-silenced cells is not merely a consequence of in-
creased ligand production but reflects a change in the compe- inhibitors U0126 or PD184352 abrogated membrane ruffling
suggesting that membrane ruffling was dependent on the ERK-tence to bind the ligand. As a functional measure of 1-integrin
activity, we measured the adhesion of control and Fra-1- MAPK pathway. Recently, overexpression of urokinase-type
plasminogen activator receptor (uPAR) has been shown to resultsilenced cells to extracellular matrix components. Figure 4E
shows that silencing Fra-1 increased 1-dependent cell adhe- in the migration of fibroblasts through the activation of Rac
(Kjoller and Hall, 2001). Both the Ras-ERK-MAPK pathway andsion to the 1 ligands fibronectin, laminin, and collagen but not
to vitronectin, which is not a 1 ligand. As expected, adhesion AP-1 have been suggested to regulate uPAR expression (Aguirre
Ghiso et al., 1999; Dang et al., 1999; Muller et al., 2000). In BEto fibronectin, laminin, and collagen was abrogated in the pres-
ence of the1-integrin blocking antibody AIIB2. Moreover, treat- cells, we found that uPAR expression was dependent on the
ERK-MAPK pathway, since accumulation of the uPAR mRNAment of control BE cells with the 1-activating antibody TS2/
16 mimicked the effect of silencing Fra-1. These results demon- was inhibited after addition of the Mek1/2 inhibitor PD184352
(Figure 6B). Silencing of Fra-1 by RNAi reduced uPAR mRNAstrate that Fra-1 functions to keep 1-integrins in an inactive
state. In addition, the observation that in Fra-1-silenced cells, levels by at most 20% demonstrating that uPAR expression is
mainly Fra-1 independent (Figure 6B). To test whether uPARactivated 1 was present in fibrillar structures (Figure 4A) sug-
gests that the activated1-integrins cluster after silencing Fra-1. was required for Rac activity in BE cells, we treated cells with
a blocking antibody against uPAR or siRNAs. The monoclonalClustering of integrins increases avidity for ligands (Humphries,
2000) and can be modulated by intracellular signaling pathways antibody R3, which recognizes the D1 domain, essential for the
binding of uPA and vitronectin has been shown to block Rac(Stewart et al., 1998). Interestingly co-staining with antibodies
against fibronectin and activated 1 showed that the fibrillar activation in cells transfected with uPAR (Kjoller and Hall, 2001).
Treatment of BE cells with antibody R3 inhibited Rac activitystructures consisted of strands of fibronectin connecting acti-
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Figure 4. Fra-1 silencing leads to 1-integrin activation
A: BE cells were transfected with siRNAs, incubated 48 hr, fixed but not permeabilized, then stained with anti-pan 1-integrin antibody (P5D2) or antiactive
1-integrin antibodies (9EG7, HUTS-21, 12G10). Bars, 15 m.
B: Fixed but not permeabilized control and Fra-1-silenced cells were stained with anti-extracellular fibronectin antibody (FN-15). Bars, 15 m.
C: Immunoblot analysis of fibronectin protein accumulation in control or Fra-1-silenced cells.
D: BE cells were transfected with scrambled or fosL1 siRNAs, incubated 48 hr, detached from the plates, then human fibronectin (150 g/ml) was added
and the cells replated. After a further 24 hr incubation, the cells were fixed and stained for active 1-integrin (9EG7).
E: BE cells were transfected with siRNAs, incubated 48 hr, then detached from the plates using a nonenzymatic cell dissociation buffer (Gibco 13151-014).
Activating (TS2/16) or blocking (AIIB2) 1-integrin antibodies were added where appropriate, cells incubated 15 min in suspension at 37C, then plated on
different extracellular matrix protein coated wells for 15 min (fibronectin, collagen I) or 30 min (laminin, vitronectin). Quantitative adhesion assays were
performed using the cytomatrix screening kit (Chemicon international).
F: Fra-1-silenced BE cells were costained for active 1-integrin (9EG7), fibronectin, and actin.
by approximately 50% (Figure 6C, upper panel). In confirmation ence of active RhoA (Figure 6E). Furthermore, Rac-dependent
cell spreading and motility resulting from overexpression ofof these results, silencing uPAR expression resulted in loss of
uPAR in 293T cells was blocked by expression of RhoAV14actin-rich membrane ruffles (Figure 6D) and reduced Rac-GTP
(Supplemental Figure S3 on website).levels (Figure 6C, lower panel). These results argue that in BE
tumor cells, uPAR drives Rac activation.
The results presented above indicate that a high Rho activity Discussion
inhibits the formation of uPAR-Rac-driven protrusions in BE
cells. We further confirmed this by showing that, in BE cells, We have shown that ERK-MAPK signaling acts to regulate Rho
the polarized phenotype can be increased by more than 2-fold and Rac activity in colon carcinoma cells and thereby plays a
major role in cell motility and invasion. ERK-dependent tran-by overexpressing uPAR, and this increase is abolished in pres-
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Figure 5. Rho is activated by a 1-integrin-dependent signaling
A: BE cells were transfected with scrambled or fosL1 siRNAs together with scrambled or 1-integrin-specific siRNAs, incubated for 48 hr then fixed and
stained with anti-pan 1-integrin antibody (P5D2) or antiactive 1-integrin antibody (9EG7). Bars, 15 m.
B: Upper panel: Fra-1- and 1-integrin-silenced BE cells were subjected to pulldown assays for Rho-GTP. Total cell lysates were immunoblotted for RhoA,
Fra-1, and GAPDH. Lower panel: BE cells were transfected with scrambled or fosL1 siRNAs, incubated 48 hr, detached from the plates, the 1-integrin-
blocking antibody AIIB2 (10 g/ml) added, and the cells replated. After 24 hr incubation, RhoA pulldown assays were performed.
C: BE cells were transfected with the fosL1 or scrambled siRNAs, incubated 24 hr, TS2/16 1-integrin-activating antibody added, and cells incubated for
24 hr before performing a RhoA pulldown assay.
D: BE cells were microinjected with EF-RhoA-V14 or Pcagg-ROCK3 and EGFP-C1, incubated for 6 hr, and fixed. Cells were stained with antiactive 1-
integrin antibody (9EG7) or anti-vinculin antibody. Microinjected cells were identified using GFP fluorescence.
scriptional activation of the fosL1 gene leads to its product, into membrane protrusions. Thus inhibition of this pathway by
Fra-1 is necessary to allow the extension of the ruffles intoFra-1, repressing Rho-GTP levels through inactivation of 1-
integrin signaling. This depression of Rho-GTP levels is neces- active protrusions required for cell motility. In addition to the
regulation of Rho-GTP levels, the activation of Rac is also regu-sary to prevent signaling by the Rho effector ROCK, which
would lead to the formation of excessive stress fibers and focal lated through ERK signaling via expression of the receptor for
urokinase type plasminogen activator, uPAR. This receptor hasadhesions. Activation of this pathway prevents membrane ruf-
fles, mediated by the small GTPase Rac, from being extended been shown to mediate Rac activation via binding to integrins
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Figure 6. Ruffling is controlled by an ERK-uPAR-
Rac pathway
A: BE cells were microinjected with EF-Rac-N17
and EGFP-C1 and incubated for 6 hr. Microin-
jected cells were identified using GFP fluores-
cence. Texas red-coupled phalloidin was used
to visualize F-actin.
B: Northern blot analysis of uPAR and Fra-1
expression in BE cells treated with PD184352 (1
M) or transfected with the fosL1 or scrambled
siRNAs for 48 hr. Levels of uPAR mRNA normalized
to GAPDH levels in PD184352-treated cells:
t0(100%), t2(43%), t4(22%), t8(13%), t24(11%); in
siRNA transfected cells: control(100%), fosL1
(83%).
C: Upper panel: BE cells were incubated 18 hr
with R3 uPAR antibodiy (30 g/ml) before a Rac
pulldown assay was performed. Lower panel: BE
cells were transfected with uPAR or scrambled
siRNAs and lysed 72 hr later and a Rac pulldown
assay performed.
D: Immunofluorescence analysis of uPAR and
F-actin expression in BE cells, 72 hr after transfec-
tion of uPAR or scrambled siRNAs. Bars, 15 m.
E: BE cells were microinjected with EGFP-C1, PRc/
CMV-uPAR, and EF-RhoA-V14, then incubated
6 hr. Microinjected cells were identified using GFP
fluorescence or staining with anti-myc antibody.
The polarized phenotype and the formation of
protrusions were evaluated by measuring the
length/width ratios. A minimum of 20 cells was
measured in two independent experiments. Val-
ues represent mean SD of the two experiments.
P values were calculated, (C) compared to con-
trol cells, (U) compared to uPAR-expressing cells.
(Kjoller and Hall, 2001) and may be independent or dependent which are both achieved through Ras-ERK-MAPK signaling.
on uPA binding (Sturge et al., 2002). We show that uPAR expres- Previous studies have shown that overexpression of p190Rho-
sion is regulated by the ERK-MAPK pathway but is a transcrip- GAP to downregulate Rho-GTP levels initiates the formation of
tional target largely independent of Fra-1 in these cells. These protrusions and promotes migration (Arthur and Burridge, 2001;
data establish a model in which motility and invasiveness of Nakahara et al., 1998). Interestingly, integrins such as 1-integ-
colon carcinoma cells are coordinated by two signaling path- rin have been suggested to modulate p190RhoGAP activity and/
ways downstream of ERK. One component is a Fra-1-depen- or localization (Arthur et al., 2000; Nakahara et al., 1998; Sharma,
dent pathway leading to the downregulation of RhoA necessary 1998). It is possible that the 1-integrin inactivation induced by
for the extension of the ruffles into active extending protrusions. Fra-1 might allow p190RhoGAP localization at the cell mem-
The second component is a Fra-1-independent uPAR-depen-
brane that permits the Rac-dependent extension of protrusionsdent pathway leading to the activation of Rac1 and the initial
by locally reducing Rho activity. A reduction in Rho activity mayformation of ruffles (see Figure 7).
also promote cell motility by facilitating the turnover of focal
adhesions necessary for cell movement (Ilic et al., 1995; NobesCoordinated control of Rho family GTPase activity by
and Hall, 1999; Parsons et al., 2000). Consistent with this, silenc-ERK-MAP kinases contributes to motility of tumor cells
ing Fra-1 led to the formation of very large Rho-dependent focalThe results presented above indicate that efficient motility of
colon carcinoma cells requires low Rho and high Rac activities, complexes (Figure 2B). Our results demonstrating the roles that
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Figure 7. ERK-dependent signaling pathways
regulating motility of colon carcinoma cells
ERK-MAP kinase signaling plays in regulating Rho and Rac different threshold levels of Rho activity regulate cell growth
and motility. High levels of Rho activity may be required to driveactivity are in disagreement with recent studies showing that
overexpression of oncogenic Ras leads to the downregulation ROCK-dependent cell contraction and antagonize cell motility
whereas lower levels of activity may allow cell proliferation. It isof Rac and the upregulation of Rho (Zondag et al., 2000; Sahai
et al., 2001). However, in Ras-transformed fibroblasts with ele- worth noting that low levels of Rho activity in BE cells contribute
positively to cell motility because total inhibition of Rho andvated Rho-GTP levels, signaling through ROCK is downregu-
lated to permit cell motility (Sahai et al., 2001). In agreement ROCK slightly inhibited motility of the control cells by interfering
with the cell body translation (Figure 3G and data not shown);with our conclusions, studies of Rho and Rac activation follow-
ing PDGF stimulation show activation of Rac and the downregu- this may explain why complete inhibition of Rho and ROCK only
partially restored motility upon Fra-1 inhibition.lation of Rho, inducing cell motility (Sander et al., 1999; Zondag
et al., 2000). Thus a consistent theme of Rac-driven cell motility
is that it requires signaling through ROCK to be low; this can Fra-1 and integrin function
We have shown that in BE tumor cells in response to Fra-1be achieved by ERK-MAPK signaling downstream of Ras either
through Fra-1-mediated suppression of Rho-GTP levels or un- silencing, 1-integrins switch to an active, ligand binding state,
which indicates that Fra-1 keeps 1-integrins in an inactive statecoupling ROCK from Rho-GTP (Sahai et al., 2001).
We have previously shown that Rho activity is required in without affecting the expression levels of 1-integrin. This effect
of Fra-1 downregulates 1-dependent cell adhesion and activa-BE cells to prevent p21Waf1 accumulating to growth inhibitory
levels; therefore, conflicting changes in Rho activity may be tion of RhoA. These results suggest that either through transcrip-
tional or nontranscriptional mechanisms, Fra-1 may interfererequired to promote the growth and motility of tumor cells.
These apparently contradictory results may be reconciled if with the process of integrin “activation” or “inside-out signaling,”
which is the modulation of integrin affinity for the extracellulardifferent Rho effector pathways are utilized to promote growth
and motility. In Ras-transformed fibroblasts, downregulation of ligands in response to intracellular signals (Hughes and Pfaff,
1998). Suppression of integrin activation has been shown to beROCK signaling is crucial for ERK-dependent motility but ROCK
signaling is not involved in the regulation of p21Waf1 levels (Sahai an important function of oncogenic Ras-Raf pathway (Hughes
et al., 1997). While the mechanism through which Fra-1 medi-et al., 2001), and neither does ROCK regulate p21Waf1 levels in BE
cells (Sahai et al., 2001). Furthermore, although ERK signaling ates 1-integrin inactivation remains to be defined, it could
regulate the expression of cytoplasmic or membrane proteinsdownregulates Rho-ROCK signaling by suppressing Rho activa-
tion, in BE cells it promotes the expression of another Rho which are known to interact with integrins, and which may be
implicated in the “activation” process, such as paxillin,-actinin,effector, mDia (E.S. and E.V., unpublished observations); thus
signaling through other Rho effectors involved in promoting cell talin, filamin, or FAK (Hughes and Pfaff, 1998). Alternately, Fra-1
might directly modify the integrin composition at the cell surface,proliferation may be maintained. An alternative possibility is that
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Experimental proceduresdepriving 1-integrin from its appropriate partner. Fra-1 modu-
lation of 1-integrin function may also occur through AP-1-
Cell culture and reagentsregulated transcription, altering the extracellular matrix com-
BE and Hct-116 human colon carcinoma cell lines were grown routinely in
position in a way which deprives the 1-integrin complexes DMEM supplemented with 10% fetal calf serum (FCS). Human fibronectin
expressed at the cell surface from their activating ligands, such (BD Biosciences 356008) was added to the media at a concentration of 150
g/ml. The BE-GFP cell line is a pool of puromycin-resistant clones gener-as laminin or fibronectin. We found that expression of fibronectin
ated by cotransfection of BE cells with pBabepuro and EF-GFP. U0126 waswas increased in Fra-1-silenced cells; however, addition of ex-
dissolved in EtOH and used at 10 M (Promega #V1121), PD184352 (Sebolt-ogenous fibronectin was not sufficient to convert 1-integrin to
Leopold et al., 1999) (gift from P. Cohen) was used at 1 M, Y-27632 (Tocris)
its active state, arguing that Fra-1 affects integrin activation was used at 10 M, and TAT-C3 (Sahai et al., 2001) was used at 0.5 M
more directly than merely through affecting the composition in cell culture media.
of the extracellular matrix. Additionally, the presence in Fra-1-
Antibodies and DNA constructssilenced cells of activated 1-integrin in fibronectin containing
Antibodies to AP-1 components were from Santa Cruz: anti-Fra-1 (sc-605),fibrillar structures connecting adjacent cells suggests that Fra-1
anti-c-Jun (sc-7481), anti-JunB (sc-46), anti-Fra-2: (sc-171), anti-c-Fos (sc-
can also affect integrin clustering. Integrin clustering increases 052). Other antibodies: anti--tubulin: Sigma (T4026), anti-RhoA: Santa Cruz
the avidity for binding ligands (Humphries, 2000; Stewart et al., (sc-418), anti-Rac1: Upstate Biotechnology (05-389), anti-Cdc42: Santa Cruz
1998) and thereby enhances adhesion and signaling. (sc-8401), anti-vinculin: Sigma (V4505), anti-myc (9E10): ICR (Sutton, United
Kingdom), anti-Pan 1-integrin (P5D2): Santa Cruz (sc-13590), anti-activeIt has been suggested that cell migration requires a dynamic
1-integrin: (9EG7) BD pharmingen (550531) and (HUTS-21) BD pharmingenadhesion and de-adhesion process reflecting activation and
(556048), anti-1-integrin antibodies 12G10, 15/7, HUTS-4, and K20 were
inactivation of integrins and that maintaining integrins in their gifts form M. Humphries, blocking 1-integrin (AIIB2) was a gift from F. Watt,
active state inhibits motility (Kuijpers et al., 1993). Our data anti-fibronectin: (EP5) Santa Cruz (sc-8422) for Western blotting and (FN-15)
suggest that in cells where there is constitutive activation of the Sigma (F7387) for immunofluorescence, anti-GAPDH: RDI (TRK5G4-6C5),
anti-uPAR: American Diagnostica (3931), R3 anti-uPAR: L. Kjoller, TS2/16:ERK-MAPK pathway, the balance between integrin activation
ATCC (HB-243), secondary antibodies for immunofluorescence from Jack-and inactivation is shifted toward inactivation to favor Rac-
son Stratech (Luton, United Kingdom).driven motility. However, a dynamic process of adhesion and
EF-RhoA-V14 and EF-Rac-N17 plasmids were gift from R. Treisman,
de-adhesion predicts that some active 1-integrin will be re- EF-DiaNC is described elsewhere (Sahai and Marshall, 2002); pCagg-
quired for cell motility. Indeed we observed that ablation of 1- ROCK3 expressing an active version of ROCK1 (ROCK1C) is a gift from
S. Narumiya. EGFP-C1 was from Clontech; pRc/CMV-uPAR is a gift fromintegrin by siRNA reduced motility of BE cells (data not shown),
L. Kjoller.consistent with this idea that some 1-integrin signaling is re-
quired for the motility of these cells.
RNAi
Desalted and deprotected synthetic oligonucleotides were purchased from
Ras-Raf-ERK signaling and tumor cell invasion Dharmacon (Lafayette, Colorado) and were annealed following their standard
protocol. The siRNA sequence targeting human Fra-1 is CACCAUGAGUGGOur studies show important roles of ERK-MAP kinase signaling
CAGUCAG; human 1-integrin: UGAGCUUCUCUGCUGUUCC; humanin tumor cell invasion. This signaling pathway may regulate the
uPAR: GGUGAAGAAGGGCGUCCAA. Control oligonucleotides correspondactivity of the Rho and Rac GTPases via the expression of
to the inverse sequences. SiRNAs were transfected using the oligofectamine
Fra-1 and uPAR. Studies from Ozanne and collaborators have reagent (Invitrogen).
indicated an important role for AP-1 in mediating tumor cell
invasion. Many of the genes that they have identified, such as Biochemical methods
Northern blot analyses were performed using conventional methods. Radio-CD44 and TSC-36, that are regulated through elevated AP-1
active probes were coding sequences of human uPAR, fosL1, and glyceral-activity following v-Fos expression have been shown to play a
dehyde 3-phosphate dehydrogenase (GAPDH) genes. Accumulation of therole in invasion (Johnston et al., 2000; Lamb et al., 1997). Our
mRNAs was quantified using a phosphorimager (Molecular Dynamics).
studies provide a further link between AP-1 and invasion by For Western blot analysis of tubulin, GAPDH, and fibronectin accumula-
showing how AP-1 activity regulates the activity of Rho. The tion, total cell lysate was used. For Western blot analysis of Fra-1 and for
DNA binding assays, cells were washed twice in ice-cold PBS, recoveredpresence of Fra-1 and uPAR in tumors, which are easily detect-
by scraping, centrifuged and resuspended in 1 volume of 20 mM Hepes (pHable, might give valuable information in the choice of the thera-
7.9), 600 mM KCl, 0.2 mM EDTA, 1 mM DTT, 1 mM vanadate, 1 mM PMSF,peutic strategy since Fra-1 and uPAR are likely to be associated
1% aprotinin. After a 30 min incubation at 0C, the lysate was centrifuged
with an high Ras-ERK-MAPK activity rather than a high Rho and the supernatant added to 1 volume of 20 mM Hepes (pH 7.9), 0.2 mM
activity. Recently, Bernards and Weinberg (Bernards and Wein- EDTA, 1 mM DTT, 40% glycerol, 1 mM vanadate, 1 mM PMSF, 1% aprotinin.
berg, 2002) have questioned whether there are separate genes Small G protein pulldown assays were performed using GST-PAK-CRIB
or GST-rhotekin as previously described (Sahai et al., 2001).for metastasis/invasion and suggested that these phenotypes
may be the consequence of the action of oncogenes and tumor
Microinjections and immunofluorescencesuppressor genes regulating cell proliferation or survival. Our
For microinjections, all plasmids were injected in Phosphate-buffered saline
results support this notion since they show that ERK-MAP ki- (PBS) at a concentration of 100 ng/l, except EGFP-C1, which was at 25
nase signaling downstream of the oncogene Ras, known to be ng/l.
For immunofluorescence, cells were washed with PBS, fixed with 4%involved in tumor cell proliferation and survival, is also involved
formaldehyde in PBS and usually permeabilized with 0.2% Triton X-100 inin invasion and cell motility. However, since the outcome of
PBS. After several PBS washes, cells were stained for the actin cytoskeletonERK-MAP kinase signaling is dependent on cellular context
with Texas red–phalloidin (Molecular Probes) or primary antibodies were
(Marshall, 1995), it is possible that the requirement for ERK added for 1 hr; after several PBS washes, appropriate secondary antibodies
signaling for cell motility and invasion will be dependent on cell were added for 1 hr; cells were mounted after several further PBS washes
and viewed using a Bio-Rad MRC1024 confocal microscope. Microinjectedtype and cooperating genetic changes.
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ligand and manganese, but inhibited by calcium. J. Biol. Chem. 270, 25570–cells were identified by GFP fluorescence or using 9E10 antibody for myc-
25577.tagged constructs.
Bernards, R., and Weinberg, R.A. (2002). A progression puzzle. Nature 418,
Biological methods 823.
The motility of cells was determined by recording phase contrast and GFP
Cox, E.A., Sastry, S.K., and Huttenlocher, A. (2001). Integrin-mediated adhe-fluorescence images once every 2 min with a multichannel timelapse digital
sion regulates cell polarity and membrane protrusion through the Rho familyvideo-microscope for several hours (Digital Pixel). The recordings were
of GTPases. Mol. Biol. Cell 12, 265–277.played back and the movement of the cells over a 6 hr period was traced
manually. The lengths of the tracings were measured with a ruler, scaled Dang, J., Boyd, D., Wang, H., Allgayer, H., Doe, W.F., and Wang, Y. (1999).
appropriately, and divided by six to give the distance moved per hour. In A region between -141 and -61 bp containing a proximal AP-1 is essential
all videos, the format is 24 frames (48 min real time) per second. for constitutive expression of urokinase-type plasminogen activator receptor.
To assess for the formation of polarized morphology and protrusions, Eur. J. Biochem. 264, 92–99.
the length/width ratio was calculated.
Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague,The inverse invasion assay was performed as previously described
J., Woffendin, H., Garnett, M.J., Bottomley, W., et al. (2002). Mutations of(Malliri et al., 1998). In brief, 40 hr after transfection of the siRNAs, BE-GFP
the BRAF gene in human cancer. Nature 417, 949–954.cells were allowed to attach to the underside (bottom) of the growth factor-
depleted Matrigel-coated polycarbonate chambers (Transwells 8 m pore del Pozo, M.A., Price, L.S., Alderson, N.B., Ren, X.D., and Schwartz, M.A.
size filters). The cells were then chemoattracted (10% FCS) across the filter (2000). Adhesion to the extracellular matrix regulates the coupling of the
small GTPase Rac to its effector PAK. EMBO J. 19, 2008–2014.and through the Matrigel above. Cells were fixed in 4% paraformaldehyde
and GFP fluorescence was analyzed in z-sections (1 section every 4 m)
Downward, J. (1998). Ras signalling and apoptosis. Curr. Opin. Genet. Dev.
from the bottom of the filter using a confocal microscope (Bio-Rad
8, 49–54.
MRC1024). Three-dimensional reconstructions of the GFP-expressing cells
into the Matrigel and then pixel quantification were done using the Volocity Hall, A. (1998). Rho GTPases and the actin cytoskeleton. Science 279,
509–514.computer software (Improvision). Percentage of invading cells is the ratio of
pixels above the filter (into Matrigel) to the total number of pixels above and
Hughes, P.E., and Pfaff, M. (1998). Integrin affinity modulation. Trends Cell
below the filter. Biol. 8, 359–364.
Adhesion assays were performed using the cytomatrix screen kit (Chem-
Hughes, P.E., Renshaw, M.W., Pfaff, M., Forsyth, J., Keivens, V.M.,icon International) according to their protocol.
Schwartz, M.A., and Ginsberg, M.H. (1997). Suppression of integrin activa-
tion: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell 88,Acknowledgments
521–530.
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